Does lapatinib have potential in early management of progressive prostate cancer?

Posted on August 12, 2011 by Sitemaster

A recently published report of a Phase II clinical trial conducted by the Eastern Cooperative Oncology Group (ECOG) suggests that  the tyrosine kinase inhibitor (TKI) lapatinib (Tykerb) may have clinically significant effects in the treatment of men with progressive prostate cancer after first-line therapy. … READ MORE …

Filed under: Drugs in development, Management, Treatment | Tagged: | 3 Comments »

Tykerb not effective in treatment of prostate cancer

Posted on January 19, 2010 by Sitemaster

Like many other drugs before it, lapatinib (Tykerb/GlaxoSmithKline) appears to have very limited clinical activity in prostate cancer according to a recently published report. … READ MORE …

Filed under: Drugs in development | Tagged: , , | 2 Comments »

  • Donate

  • PCaI’s ASVSG

    If you are on or thinking about active surveillance (AS) as a way to manage your low-risk prostate cancer, you may want to join Prostate Cancer International’s Active Surveillance Virtual Support Group.

  • CureTalks on PCa

    Our most recent CureTalk on Prostate Cancer (on February 21 this year)  features Eli Van Allen, MD, of the Broad Institute and the Dana-Farber Cancer Center, talking about the new “Metastatic Prostate Cancer Project” and how you can become part of the solution.

    For access to the full list of CureTalks on Prostate Cancer, please click here.

  • Disclaimer

    News and information provided on this site should not be used for diagnosing or treating any health problem or disease.

    The “New” Prostate Cancer InfoLink is intended for informational purposes only. It is not engaged in rendering medical advice or professional services and is not a substitute for professional care. If you have or suspect you may have a health problem, please consult your healthcare provider.

  • Hot Posts …

  • … and Archives